15:59 May 29

Ipca Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1524.40
-48.00 (-3.05%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ipca Laboratories Ltd. Financials

Ipca Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1524.40
-48.00 (-3.05%)
15:59 May 29
Quality
image/svg+xml

97/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

57/100
Technically Neutral

Strength

11

Weakness

7

Opportunity

1

Threats

0

14.15 %

ROE %

9.22 %

ROA %

44.98

EPS

317.85

BVPS

11.82 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
5829.79 6244.32 7705.04 8939.59 9646.33
Operating Expenses +
4520.53 5317.55 6383.88 7213.45 7667.77
Raw Material
2144.5 2205.84 2706.39 2824.6 2876.63
Increase Decrease in Cost
-129.65 100.67 -130.64 -46.05 -53.91
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1177.39 1287.64 1708.43 1983.99 2160.2
Miscellaneous Expenses
2288.89 2717.78 3079.84 3546.47 3750.09
Operating Profit
1309.26 926.77 1321.16 1726.14 1978.56
Other Income
66.57 125.62 124.77 92.8 174.45
Depreciation
232.42 261.56 357.24 397.82 418.12
Interest
7.69 45.54 138.27 84.93 75.94
Profit before tax and exceptio..
1135.72 745.29 950.42 1336.19 1658.95
Exceptional Items
0 0 -107.75 -205.05 -86.43
PBT
1135.72 745.29 842.67 1131.14 1572.52
Provision for Taxation
224.77 253.36 313.46 343.61 381.15
Net Profit
910.95 491.93 529.21 787.53 1191.37
NET Profit after MI
884.08 471.32 547.35 737.68 1141.12
EPS
34.85 18.58 21.57 29.08 46.94
Operating Profit Margin (%)
22.46 14.84 17.15 19.31 20.51
Net Profit Margin (%)
15.16 7.55 7.1 8.25 11.83

Ipca Laboratories Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 44.70 44.70 44.70 44.70 44.70 44.70
FII 10.60 10.60 10.40 10.70 10.80 11.10
Public 37.50 37.30 36.80 36.20 36.00 35.60
Others 7.20 7.40 8.10 8.40 8.50 8.60
Shareholder Shares Holding %
Download Our App On: